University of Maryland, Baltimore and Serenta Team Up to Fight Staph Infections
June 1, 2017 – License agreement gives Serenta exclusive rights to a vaccine for prevention of Staph aureus infections, a deadly disease leading to the hospitalization of 1.2 million Americans, affecting millions more BALTIMORE AND GAITHERSBURG, MD, May 31, 2017 …
